US Stock MarketDetailed Quotes

AEON AEON Biopharma

Watchlist

1.340
-0.210-13.55%

Close Jun 18 16:00 ET

1.410
+0.070+5.22%

Post 18:31 ET

52.42MMarket Cap-129P/E (TTM)

AEON Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Total revenue

-24.99%2.52M

3.36M

Operating revenue

--0

----

--0

-24.99%2.52M

--3.36M

Cost of revenue

Gross profit

-24.97%2.52M

3.36M

Operating expense

-20.43%10.38M

13.05M

31.31%48.43M

15.03M

9.91M

95.08%36.88M

-63.45%18.91M

51.73M

Selling and administrative expenses

21.04%4.65M

----

--3.84M

22.61%13.68M

--5.5M

--2.44M

-3.75%11.15M

-74.83%11.59M

--46.04M

Research and development costs

-37.73%5.73M

----

--9.21M

35.08%34.75M

--9.53M

--7.48M

251.52%25.73M

52.04%7.32M

--4.81M

Depreciation amortization depletion

----

--0

--875K

-Depreciation and amortization

----

--0

--875K

Operating profit

20.43%-10.38M

-13.05M

-31.31%-48.43M

-15.03M

-9.91M

-125.05%-36.88M

66.12%-16.39M

-48.37M

Net non-operating interest income expense

99.78%-15K

-6.75M

Non-operating interest income

----

--0

--720K

Non-operating interest expense

----

-99.80%15K

--7.47M

Other net income (expense)

-2,243.50%-107.64M

-4.59M

78.00%-4.13M

-19.53M

-525K

-13.60%-18.76M

-108.22%-16.51M

200.79M

Gain on sale of security

---43.82M

----

100.70%346K

---49.3M

Earnings from equity interest

----

-102.08%-140K

--6.73M

Special income (charges)

---63.77M

----

--0

-160.91%-28.97M

-104.37%-11.1M

--254.11M

-Less：Restructuring and merger&acquisition

--63.77M

----

--0

----

-Less:Other special charges

----

160.91%28.97M

--11.1M

----

-Gain on sale of business

----

--0

--254.11M

Other non- operating income (expenses)

98.95%-48K

----

---4.59M

-140.42%-4.13M

---19.53M

---525K

281.87%10.21M

47.78%-5.61M

---10.75M

Income before tax

-569.07%-118.02M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-69.04%-55.64M

-122.59%-32.91M

145.67M

Income tax

-14.65M

Net income

-569.07%-118.02M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-69.04%-55.64M

-120.53%-32.91M

160.32M

Net income continuous Operations

-569.07%-118.02M

----

---17.64M

5.54%-52.56M

---34.56M

---10.44M

-69.04%-55.64M

-120.53%-32.91M

--160.32M

Minority interest income

-12.61M

Net income attributable to the parent company

-569.07%-118.02M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-69.04%-55.64M

-119.03%-32.91M

172.92M

Preferred stock dividends

Other preferred stock dividends

-5.47M

Net income attributable to common stockholders

-569.07%-118.02M

-17.64M

5.54%-52.56M

-34.56M

-10.44M

-102.73%-55.64M

-115.87%-27.44M

172.92M

Basic earnings per share

-295.30%-3.17

-0.8019

5.54%-2.3893

-1.5713

-0.4745

-36.72%-2.5294

-115.83%-1.85

11.6865

Diluted earnings per share

-295.30%-3.17

-0.8019

5.54%-2.3893

-1.5713

-0.4745

-36.72%-2.5294

-115.83%-1.85

11.6865

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Total revenue	0		0	0	0	0	0	-24.99%2.52M	3.36M
Operating revenue	--0	----	--0	--0	--0	--0	--0	-24.99%2.52M	--3.36M
Cost of revenue								0	1K
Gross profit								-24.97%2.52M	3.36M
Operating expense	-20.43%10.38M		13.05M	31.31%48.43M	15.03M	9.91M	95.08%36.88M	-63.45%18.91M	51.73M
Selling and administrative expenses	21.04%4.65M	----	--3.84M	22.61%13.68M	--5.5M	--2.44M	-3.75%11.15M	-74.83%11.59M	--46.04M
Research and development costs	-37.73%5.73M	----	--9.21M	35.08%34.75M	--9.53M	--7.48M	251.52%25.73M	52.04%7.32M	--4.81M
Depreciation amortization depletion	----	----	----	----	----	----	----	--0	--875K
-Depreciation and amortization	----	----	----	----	----	----	----	--0	--875K
Operating profit	20.43%-10.38M		-13.05M	-31.31%-48.43M	-15.03M	-9.91M	-125.05%-36.88M	66.12%-16.39M	-48.37M
Net non-operating interest income expense								99.78%-15K	-6.75M
Non-operating interest income	----	----	----	----	----	----	----	--0	--720K
Non-operating interest expense	----	----	----	----	----	----	----	-99.80%15K	--7.47M
Other net income (expense)	-2,243.50%-107.64M		-4.59M	78.00%-4.13M	-19.53M	-525K	-13.60%-18.76M	-108.22%-16.51M	200.79M
Gain on sale of security	---43.82M	----	----	----	----	----	----	100.70%346K	---49.3M
Earnings from equity interest	----	----	----	----	----	----	----	-102.08%-140K	--6.73M
Special income (charges)	---63.77M	----	--0	--0	--0	--0	-160.91%-28.97M	-104.37%-11.1M	--254.11M
-Less：Restructuring and merger&acquisition	--63.77M	----	--0	--0	--0	--0	----	----	----
-Less:Other special charges	----	----	----	----	----	----	160.91%28.97M	--11.1M	----
-Gain on sale of business	----	----	----	----	----	----	----	--0	--254.11M
Other non- operating income (expenses)	98.95%-48K	----	---4.59M	-140.42%-4.13M	---19.53M	---525K	281.87%10.21M	47.78%-5.61M	---10.75M
Income before tax	-569.07%-118.02M		-17.64M	5.54%-52.56M	-34.56M	-10.44M	-69.04%-55.64M	-122.59%-32.91M	145.67M
Income tax	0		0	0	0	0	0	0	-14.65M
Net income	-569.07%-118.02M		-17.64M	5.54%-52.56M	-34.56M	-10.44M	-69.04%-55.64M	-120.53%-32.91M	160.32M
Net income continuous Operations	-569.07%-118.02M	----	---17.64M	5.54%-52.56M	---34.56M	---10.44M	-69.04%-55.64M	-120.53%-32.91M	--160.32M
Minority interest income								0	-12.61M
Net income attributable to the parent company	-569.07%-118.02M		-17.64M	5.54%-52.56M	-34.56M	-10.44M	-69.04%-55.64M	-119.03%-32.91M	172.92M
Preferred stock dividends
Other preferred stock dividends								-5.47M
Net income attributable to common stockholders	-569.07%-118.02M		-17.64M	5.54%-52.56M	-34.56M	-10.44M	-102.73%-55.64M	-115.87%-27.44M	172.92M
Basic earnings per share	-295.30%-3.17		-0.8019	5.54%-2.3893	-1.5713	-0.4745	-36.72%-2.5294	-115.83%-1.85	11.6865
Diluted earnings per share	-295.30%-3.17		-0.8019	5.54%-2.3893	-1.5713	-0.4745	-36.72%-2.5294	-115.83%-1.85	11.6865
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall